Transcriptional control mechanisms associated with the nucleotide receptor P2X7, a critical regulator of immunologic, osteogenic, and neurologic functions

[1]  L. Brovko,et al.  Signaling through P2X7 receptor in human T cells involves p56lck, MAP kinases, and transcription factors AP-1 and NF-κB. , 2011, The Journal of Biological Chemistry.

[2]  F. Di Virgilio,et al.  P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema. , 2011, American journal of respiratory cell and molecular biology.

[3]  M. Fleshner,et al.  Long-term voluntary wheel running is rewarding and produces plasticity in the mesolimbic reward pathway , 2011, Behavioural Brain Research.

[4]  J. Watters,et al.  The P2X7‐Egr pathway regulates nucleotide‐dependent inflammatory gene expression in microglia , 2011, Glia.

[5]  W. Junger,et al.  Hypertonic stress regulates T cell function via pannexin‐1 hemichannels and P2X receptors , 2010, Journal of leukocyte biology.

[6]  K. Sakamoto,et al.  The Role of the Transcription Factor CREB in Immune Function , 2010, The Journal of Immunology.

[7]  Lin Sun,et al.  Metaanalysis of P2X7 gene polymorphisms and tuberculosis susceptibility. , 2010, FEMS immunology and medical microbiology.

[8]  E. Nikolsky,et al.  Ticagrelor: An investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome , 2010, Vascular health and risk management.

[9]  P. Kubes,et al.  Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation , 2010, Science.

[10]  M. Gavala,et al.  Activation of the Transcription Factor FosB/Activating Protein-1 (AP-1) Is a Prominent Downstream Signal of the Extracellular Nucleotide Receptor P2RX7 in Monocytic and Osteoblastic Cells* , 2010, The Journal of Biological Chemistry.

[11]  V. Kumar,et al.  Association of P2X7 receptor +1513 (A-->C) polymorphism with tuberculosis in a Punjabi population. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[12]  M. Gavala,et al.  Extracellular ATP May Contribute to Tissue Repair by Rapidly Stimulating Purinergic Receptor X7-Dependent Vascular Endothelial Growth Factor Release from Primary Human Monocytes , 2010, The Journal of Immunology.

[13]  T. Malek,et al.  Interleukin-2 receptor signaling: at the interface between tolerance and immunity. , 2010, Immunity.

[14]  P. Beswick,et al.  Synthesis and biological activity of a series of tetrasubstituted-imidazoles as P2X(7) antagonists. , 2010, Bioorganic & medicinal chemistry letters.

[15]  Mia M. Thi,et al.  Fluid Flow-induced Soluble Vascular Endothelial Growth Factor Isoforms Regulate Actin Adaptation in Osteoblasts* , 2010, The Journal of Biological Chemistry.

[16]  N. Dalgıç,et al.  POLYMORPHISM IN THE P2X7 GENE INCREASES SUSCEPTIBILITY TO EXTRAPULMONARY TUBERCULOSIS IN TURKISH CHILDREN , 2010, The Pediatric infectious disease journal.

[17]  J. Pezzuto,et al.  NFκB: a promising target for natural products in cancer chemoprevention , 2010, Phytotherapy research : PTR.

[18]  Yu-Qiu Zhang,et al.  Involvement of Spinal Microglial P2X7 Receptor in Generation of Tolerance to Morphine Analgesia in Rats , 2010, The Journal of Neuroscience.

[19]  M. Gavala,et al.  Mutation of putative N-linked glycosylation sites on the human nucleotide receptor P2X7 reveals a key residue important for receptor function. , 2010, Biochemistry.

[20]  G. Burnstock,et al.  Purinergic signalling and bone remodelling. , 2010, Current opinion in pharmacology.

[21]  P. Karakiewicz,et al.  Treatment of metastatic renal cell carcinoma , 2010, Nature Reviews Urology.

[22]  S. Senger,et al.  Synthesis and structure-activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor. , 2010, Bioorganic & medicinal chemistry letters.

[23]  Betsy S. Pierce,et al.  Discovery of 2-chloro-N-((4,4-difluoro-1-hydroxycyclohexyl)methyl)-5-(5-fluoropyrimidin-2-yl)benzamide as a potent and CNS penetrable P2X7 receptor antagonist. , 2010, Bioorganic & medicinal chemistry letters.

[24]  L. Raisz,et al.  Prostaglandins in bone: bad cop, good cop? , 2010, Trends in Endocrinology & Metabolism.

[25]  F. Di Virgilio,et al.  Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.

[26]  S. Amin.  Mechanical Factors and Bone Health: Effects of Weightlessness and Neurologic Injury , 2010, Current rheumatology reports.

[27]  M. Kassiou,et al.  P2X purinergic receptor ligands: recently patented compounds , 2010, Expert opinion on therapeutic patents.

[28]  S. Baldwin,et al.  Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2X7 receptor functions. , 2010, Journal of psychiatric research.

[29]  J. Alcocer-Varela,et al.  Early growth response transcription factors and the modulation of immune response: implications towards autoimmunity. , 2010, Autoimmunity reviews.

[30]  J. Blackwell,et al.  Evidence for associations between the purinergic receptor P2X7 (P2RX7) and toxoplasmosis , 2010, Genes and Immunity.

[31]  Masafumi Ueno,et al.  Basic principles of platelet biology and clinical implications. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[32]  Ju-Yeon Lee,et al.  Synthesis and Structure—Activity Relationships of Pyrazolodiazepine Derivatives as Human P2X7 Receptor Antagonists. , 2010 .

[33]  S. McMahon,et al.  P2X7-Dependent Release of Interleukin-1β and Nociception in the Spinal Cord following Lipopolysaccharide , 2010, The Journal of Neuroscience.

[34]  E. Chaum,et al.  Quantitative AP‐1 gene regulation by oxidative stress in the human retinal pigment epithelium , 2009, Journal of cellular biochemistry.

[35]  T. Imamura,et al.  Mechanical stress induces Interleukin-11 expression to stimulate osteoblast differentiation. , 2009, Bone.

[36]  A. Toker,et al.  NFAT proteins: emerging roles in cancer progression , 2009, Nature Reviews Cancer.

[37]  Yong‐Chul Kim,et al.  Synthesis and structure-activity relationships of pyrazolodiazepine derivatives as human P2X7 receptor antagonists. , 2009, Bioorganic & medicinal chemistry letters.

[38]  Thomas W. Mühleisen,et al.  Variation in P2RX7 candidate gene (rs2230912) is not associated with bipolar I disorder and unipolar major depression in four European samples , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[39]  Xiaoren Zhang,et al.  NF-κB Signaling Pathway, Inflammation and Colorectal Cancer , 2009, Cellular and Molecular Immunology.

[40]  T. Takano,et al.  Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury , 2009, Proceedings of the National Academy of Sciences.

[41]  P. Insel,et al.  Autocrine regulation of T‐cell activation by ATP release and P2X7 receptors , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  A. McQuillin,et al.  Case–control studies show that a non-conservative amino-acid change from a glutamine to arginine in the P2RX7 purinergic receptor protein is associated with both bipolar- and unipolar-affective disorders , 2009, Molecular Psychiatry.

[43]  G. Burnstock,et al.  P2X7 deficiency attenuates renal injury in experimental glomerulonephritis. , 2009, Journal of the American Society of Nephrology : JASN.

[44]  D. Górecki,et al.  Analysis of Assembly and Trafficking of Native P2X4 and P2X7 Receptor Complexes in Rodent Immune Cells* , 2009, Journal of Biological Chemistry.

[45]  W. Altemeier,et al.  Noninjurious mechanical ventilation activates a proinflammatory transcriptional program in the lung. , 2009, Physiological genomics.

[46]  K. Torimitsu,et al.  Direct Observation of ATP-Induced Conformational Changes in Single P2X4 Receptors , 2009, PLoS biology.

[47]  F. Di Virgilio,et al.  Expression of the P2X7 Receptor Increases the Ca2+ Content of the Endoplasmic Reticulum, Activates NFATc1, and Protects from Apoptosis* , 2009, Journal of Biological Chemistry.

[48]  S. Fuller,et al.  Genetics of the P2X7 receptor and human disease , 2009, Purinergic Signalling.

[49]  F. Bianco,et al.  Different properties of P2X7 receptor in hippocampal and cortical astrocytes , 2009, Purinergic Signalling.

[50]  M. Gavala,et al.  Cell signaling via the P2X7 nucleotide receptor: linkage to ROS production, gene transcription, and receptor trafficking , 2009, Purinergic Signalling.

[51]  A. Székely,et al.  Association between depression and the Gln460Arg polymorphism of P2RX7 Gene: A dimensional approach , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[52]  M. Decker,et al.  Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: Relevance for neuropsychiatric disorders , 2009, Behavioural Brain Research.

[53]  J. Kanellopoulos,et al.  Palmitoylation of the P2X7 receptor, an ATP‐gated channel, controls its expression and association with lipid rafts , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  S. M. Sims,et al.  Expression, signaling, and function of P2X7 receptors in bone , 2009, Purinergic Signalling.

[55]  W. Busse,et al.  Attenuated P2X7 pore function as a risk factor for virus-induced loss of asthma control. , 2009, American journal of respiratory and critical care medicine.

[56]  L. Alcaraz,et al.  Antagonists of the P2X(7) receptor. From lead identification to drug development. , 2009, Journal of medicinal chemistry.

[57]  F. Di Virgilio,et al.  1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parameters. , 2009, The Journal of clinical endocrinology and metabolism.

[58]  K. Jacobson,et al.  Corrigendum to “Synthesis and structure–activity relationship studies of tyrosine-based antagonists at the human P2X7 receptor” [Bioorg. Med. Chem. Lett. 18 (2008) 571–575] , 2009 .

[59]  A. Kataoka,et al.  Activation of P2X7 receptors induces CCL3 production in microglial cells through transcription factor NFAT , 2009, Journal of neurochemistry.

[60]  J. Krause,et al.  Characterization of N-(Adamantan-1-ylmethyl)-5-[(3R-aminopyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 Antagonist in Animal Models of Pain and Inflammation , 2008, Journal of Pharmacology and Experimental Therapeutics.

[61]  Deanna L. Wallace,et al.  The Influence of ΔFosB in the Nucleus Accumbens on Natural Reward-Related Behavior , 2008, The Journal of Neuroscience.

[62]  M. Gavala,et al.  The nucleotide receptor P2RX7 mediates ATP‐induced CREB activation in human and murine monocytic cells , 2008, Journal of leukocyte biology.

[63]  A. Vezzani,et al.  Inflammatory events in hippocampal slice cultures prime neuronal susceptibility to excitotoxic injury: a crucial role of P2X7 receptor‐mediated IL‐1β release , 2008, Journal of neurochemistry.

[64]  D. Donnelly-roberts,et al.  Selective P2X7 receptor antagonists for chronic inflammation and pain , 2008, Purinergic Signalling.

[65]  S. M. Sims,et al.  P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis , 2008, The Journal of cell biology.

[66]  J. Fleming,et al.  Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice. , 2008, Cancer research.

[67]  A. Surprenant,et al.  P2X7 Receptor Differentially Couples to Distinct Release Pathways for IL-1β in Mouse Macrophage1 , 2008, The Journal of Immunology.

[68]  M. Maes.  The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. , 2008, Neuro endocrinology letters.

[69]  B. Hassan,et al.  A Comparative Study of Interleukin-1β Production and P2x7 Expression After Atp Stimulation by Peripheral Blood Mononuclear Cells Isolated From Rheumatoid Arthritis Patients and Normal Healthy Controls , 2008, Inflammation.

[70]  Hyun B Choi,et al.  Expression and function of the P2X(7) receptor in rat C6 glioma cells. , 2008, Cancer letters.

[71]  R. Dantzer,et al.  In vitro and in vivo evidence for a role of the P2X7 receptor in the release of IL-1β in the murine brain , 2008, Brain, Behavior, and Immunity.

[72]  K. Jacobson,et al.  Synthesis and structure-activity relationship studies of tyrosine-based antagonists at the human P2X7 receptor. , 2008, Bioorganic & medicinal chemistry letters.

[73]  F. Di Virgilio,et al.  The P2X7 receptor: a key player in IL-1 processing and release , 2007, The Journal of Immunology.

[74]  M. Hoth,et al.  P2X7 receptor stimulation upregulates Egr‐1 biosynthesis involving a cytosolic Ca2+ rise, transactivation of the EGF receptor and phosphorylation of ERK and Elk‐1 , 2007, Journal of cellular physiology.

[75]  F. Di Virgilio,et al.  Liaisons dangereuses: P2X(7) and the inflammasome. , 2007, Trends in pharmacological sciences.

[76]  Y. Gwack,et al.  Signalling to transcription: store-operated Ca2+ entry and NFAT activation in lymphocytes. , 2007, Cell calcium.

[77]  G. Dubyak,et al.  Nonclassical IL-1β Secretion Stimulated by P2X7 Receptors Is Dependent on Inflammasome Activation and Correlated with Exosome Release in Murine Macrophages1 , 2007, The Journal of Immunology.

[78]  M. Barrot,et al.  Induction of ΔFosB in the Periaqueductal Gray by Stress Promotes Active Coping Responses , 2007, Neuron.

[79]  N. Jørgensen,et al.  Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment , 2007, Pharmacogenetics and genomics.

[80]  R. González-Amaro,et al.  P2X7 and NRAMP1/SLC11 A1 gene polymorphisms in Mexican mestizo patients with pulmonary tuberculosis , 2007, Clinical and experimental immunology.

[81]  M. Gavala,et al.  Nucleotide receptor signaling in murine macrophages is linked to reactive oxygen species generation. , 2007, Free radical biology & medicine.

[82]  E. Nestler,et al.  Proteasome‐dependent and ‐independent mechanisms for FosB destabilization: identification of FosB degron domains and implications for ΔFosB stability , 2007, The European journal of neuroscience.

[83]  Geoffrey Burnstock,et al.  Physiology and pathophysiology of purinergic neurotransmission. , 2007, Physiological reviews.

[84]  H. Takayanagi.  Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems , 2007, Nature Reviews Immunology.

[85]  G. Marks,et al.  A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis. , 2007, American journal of respiratory and critical care medicine.

[86]  M. Gavala,et al.  Nucleotide receptor signalling and the generation of reactive oxygen species , 2007, Purinergic Signalling.

[87]  I. Chessell,et al.  The role of P2X7 in pain and inflammation , 2007, Purinergic Signalling.

[88]  E. Marion Schneider,et al.  Role of ATP in Trauma‐Associated Cytokine Release and Apoptosis by P2X7 Ion Channel Stimulation , 2006, Annals of the New York Academy of Sciences.

[89]  A. Surprenant,et al.  Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor , 2006, The EMBO journal.

[90]  M. Barrot,et al.  The transcription factor ΔFosB is recruited by inflammatory pain , 2006 .

[91]  J. Watters,et al.  Purinergic receptors modulate MAP kinases and transcription factors that control microglial inflammatory gene expression , 2006, Neurochemistry International.

[92]  E. Shink,et al.  Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[93]  G. Angelini,et al.  Human P2X7 pore function predicts allele linkage disequilibrium. , 2006, Clinical chemistry.

[94]  L. Claesson‐Welsh,et al.  VEGF receptor signalling ? in control of vascular function , 2006, Nature Reviews Molecular Cell Biology.

[95]  W. Griffin,et al.  Inflammation and neurodegenerative diseases. , 2006, The American journal of clinical nutrition.

[96]  D. Theobald,et al.  An essential role for ΔFosB in the nucleus accumbens in morphine action , 2006, Nature Neuroscience.

[97]  R. DuBois,et al.  Fishing for prostanoids: deciphering the developmental functions of cyclooxygenase-derived prostaglandins. , 2006, Developmental biology.

[98]  Jiliang Li,et al.  The P2X7 Nucleotide Receptor Mediates Skeletal Mechanotransduction* , 2005, Journal of Biological Chemistry.

[99]  Karin Milde-Langosch,et al.  The Fos family of transcription factors and their role in tumourigenesis. , 2005, European journal of cancer.

[100]  F. Di Virgilio,et al.  A His-155 to Tyr Polymorphism Confers Gain-of-Function to the Human P2X7 Receptor of Human Leukemic Lymphocytes1 , 2005, The Journal of Immunology.

[101]  M. Rathbone,et al.  P2X7 Receptor Activation in Rat Brain Cultured Astrocytes Increases the Biosynthetic Release of Cysteinyl Leukotrienes , 2005, International journal of immunopathology and pharmacology.

[102]  P. Anand,et al.  Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain , 2005, Pain.

[103]  G. Angelini,et al.  Detection of Human P2X7 Nucleotide Receptor Polymorphisms by a Novel Monocyte Pore Assay Predictive of Alterations in Lipopolysaccharide-Induced Cytokine Production1 , 2005, The Journal of Immunology.

[104]  H. Anisman,et al.  Cytokines as a precipitant of depressive illness: animal and human studies. , 2005, Current pharmaceutical design.

[105]  C. Brosnan,et al.  The cytokine IL‐1β transiently enhances P2X7 receptor expression and function in human astrocytes , 2005, Glia.

[106]  C. McClung,et al.  DeltaFosB: a molecular switch for long-term adaptation in the brain. , 2004, Brain research. Molecular brain research.

[107]  Rosette Lidereau,et al.  Molecular Profiling of Inflammatory Breast Cancer , 2004, Clinical Cancer Research.

[108]  S. Petrou,et al.  An Arg307 to Gln Polymorphism within the ATP-binding Site Causes Loss of Function of the Human P2X7 Receptor* , 2004, Journal of Biological Chemistry.

[109]  S. Goldman,et al.  P2X7 receptor inhibition improves recovery after spinal cord injury , 2004, Nature Medicine.

[110]  M. Wewers,et al.  A Novel P2X7 Receptor Activator, the Human Cathelicidin-Derived Peptide LL37, Induces IL-1β Processing and Release1 , 2004, The Journal of Immunology.

[111]  P. Bertics,et al.  Evidence for nucleotide receptor modulation of cross talk between MAP kinase and NF-kappa B signaling pathways in murine RAW 264.7 macrophages. , 2004, American journal of physiology. Cell physiology.

[112]  S. M. Sims,et al.  Extracellular Nucleotides Act Through P2X7 Receptors to Activate NF‐κB in Osteoclasts , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[113]  J. Wiley,et al.  Glu496 to Ala Polymorphism in the P2X7 Receptor Impairs ATP-Induced IL-1β Release from Human Monocytes1 , 2004, The Journal of Immunology.

[114]  R. Korbut,et al.  Nitric oxide and superoxide in inflammation and immune regulation. , 2003, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[115]  T Kendall Harden,et al.  Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. , 2003, Molecular pharmacology.

[116]  Grace Y Sun,et al.  P2X7 nucleotide receptor activation enhances IFNγ‐induced type II nitric oxide synthase activity in BV‐2 microglial cells , 2003, Journal of neurochemistry.

[117]  S. Golding,et al.  Release and interconversion of P2 receptor agonists by human osteoblast‐like cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[118]  G. Dubyak,et al.  Mutation of a Dibasic Amino Acid Motif Within the C Terminus of the P2X7 Nucleotide Receptor Results in Trafficking Defects and Impaired Function 1 , 2003, The Journal of Immunology.

[119]  S. M. Sims,et al.  Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. , 2003, Molecular endocrinology.

[120]  S. Petrou,et al.  An Ile-568 to Asn Polymorphism Prevents Normal Trafficking and Function of the Human P2X7 Receptor* , 2003, The Journal of Biological Chemistry.

[121]  S. Petrou,et al.  Raffaello Carboni's Perception of Australia , 2003 .

[122]  B. Robertson,et al.  P2X7 Mediates Superoxide Production in Primary Microglia and Is Up-regulated in a Transgenic Mouse Model of Alzheimer's Disease* , 2003, The Journal of Biological Chemistry.

[123]  F. Di Virgilio,et al.  Stimulation of P2 purinergic receptors induces the release of eosinophil cationic protein and interleukin‐8 from human eosinophils , 2003, British journal of pharmacology.

[124]  S. Petrou,et al.  P2X7 Receptor Cell Surface Expression and Cytolytic Pore Formation Are Regulated by a Distal C-terminal Region* , 2003, The Journal of Biological Chemistry.

[125]  G. Schmalzing,et al.  Glu496Ala polymorphism of human P2X7 receptor does not affect its electrophysiological phenotype. , 2003, American journal of physiology. Cell physiology.

[126]  R. Paus,et al.  Signaling through P2X7 Receptor in Human T Cells Involves p56 lck , MAP Kinases, and Transcription Factors AP-1 and NF-κB* , 2003, Journal of Biological Chemistry.

[127]  A. Quattrini,et al.  Relief of inflammatory pain in rats by local use of the selective P2X7 ATP receptor inhibitor, oxidized ATP. , 2002, Arthritis and rheumatism.

[128]  Y. Pollak,et al.  Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment. , 2002, The international journal of neuropsychopharmacology.

[129]  Eric J. Nestler,et al.  ΔFosB Regulates Wheel Running , 2002, The Journal of Neuroscience.

[130]  L. Audoly,et al.  The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. , 2002, The Journal of clinical investigation.

[131]  A. Quattrini,et al.  Antinociceptive effect of a new P2Z/P2X7 antagonist, oxidized ATP, in arthritic rats , 2002, Neuroscience Letters.

[132]  J. Svaren,et al.  Modulation of monocyte signaling and pore formation in response to agonists of the nucleotide receptor P2X7 , 2002, Journal of leukocyte biology.

[133]  C. Gabel,et al.  Absence of the P2X7 Receptor Alters Leukocyte Function and Attenuates an Inflammatory Response , 2002, The Journal of Immunology.

[134]  G. Burnstock.  Purinergic Signaling and Vascular Cell Proliferation and Death , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[135]  N. Rothwell,et al.  Purinergic (P2X7) Receptor Activation of Microglia Induces Cell Death via an Interleukin-1-Independent Mechanism , 2002, Molecular and Cellular Neuroscience.

[136]  R. North.  Molecular physiology of P2X receptors. , 2002, Physiological reviews.

[137]  M. Romanello,et al.  Mechanically induced ATP release from human osteoblastic cells. , 2001, Biochemical and biophysical research communications.

[138]  M. Barrot,et al.  ΔFosB: A sustained molecular switch for addiction , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[139]  K. Miyata,et al.  Interleukin-11 induces osteoblast differentiation and acts synergistically with bone morphogenetic protein-2 in C3H10T1/2 cells. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[140]  G. Dubyak,et al.  Cutting Edge: The Nucleotide Receptor P2X7 Contains Multiple Protein- and Lipid-Interaction Motifs Including a Potential Binding Site for Bacterial Lipopolysaccharide1 , 2001, The Journal of Immunology.

[141]  S. Petrou,et al.  A Glu-496 to Ala Polymorphism Leads to Loss of Function of the Human P2X7 Receptor* , 2001, The Journal of Biological Chemistry.

[142]  Beverly H. Koller,et al.  Altered Cytokine Production in Mice Lacking P2X7Receptors* , 2001, The Journal of Biological Chemistry.

[143]  M. Kelz,et al.  Overexpression of ΔFosB transcription factor(s) increases bone formation and inhibits adipogenesis , 2000, Nature Medicine.

[144]  D. Kusner,et al.  ATP-Induced Killing of Virulent Mycobacterium tuberculosis Within Human Macrophages Requires Phospholipase D1 , 2000, The Journal of Immunology.

[145]  D. Surmeier,et al.  Expression of the transcription factor ΔFosB in the brain controls sensitivity to cocaine , 1999, Nature.

[146]  D. Ferrari,et al.  P2X7/P2Z Purinoreceptor-mediated Activation of Transcription Factor NFAT in Microglial Cells* , 1999, The Journal of Biological Chemistry.

[147]  P. Bertics,et al.  Purinergic Receptor Modulation of Lipopolysaccharide Signaling and Inducible Nitric-oxide Synthase Expression in RAW 264.7 Macrophages* , 1998, The Journal of Biological Chemistry.

[148]  G Burnstock,et al.  Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.

[149]  W. Griffin,et al.  Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression , 1998, Brain pathology.

[150]  D. Ferrari,et al.  Extracellular ATP Activates Transcription Factor NF-κB through the P2Z Purinoreceptor by Selectively Targeting NF-κB p65 (RelA) , 1997, The Journal of cell biology.

[151]  M. Greenberg,et al.  FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[152]  F. Di Virgilio,et al.  Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. , 1997, Journal of immunology.

[153]  C. Chiamulera,et al.  Common Neural Substrates for the Addictive Properties of Nicotine and Cocaine , 1997, Science.

[154]  Michael E Greenberg,et al.  A Defect in Nurturing in Mice Lacking the Immediate Early Gene fosB , 1996, Cell.

[155]  S K Durham,et al.  Expression of FosB during mouse development: normal development of FosB knockout mice. , 1996, Oncogene.

[156]  E. Nestler,et al.  Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. , 1996, Molecular pharmacology.

[157]  David W. Self,et al.  Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments , 1994, Neuron.

[158]  D W Dickson,et al.  Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. , 1993, Journal of immunology.

[159]  R. S. Smith.  The macrophage theory of depression. , 1991, Medical hypotheses.

[160]  A. Cohen,et al.  ATP-induced activation of human B lymphocytes via P2-purinoceptors. , 1991, Journal of immunology.

[161]  Y. Nakabeppu,et al.  A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity , 1991, Cell.

[162]  S. Sugama,et al.  Modulation of the ATP-lnduced release and processing of IL-1beta in microglial cells. , 2009, Critical reviews in immunology.

[163]  V. Sondak,et al.  Targeted therapy in melanoma. , 2013, Clinics in dermatology.

[164]  Hyun B Choi,et al.  Expression and function of the P2X(7) receptor in rat C6 glioma cells. , 2008, Cancer letters.

[165]  F. Di Virgilio,et al.  Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease? , 2008, Endocrinology.

[166]  Yoshiro Kobayashi.  The role of chemokines in neutrophil biology. , 2008, Frontiers in bioscience : a journal and virtual library.

[167]  R. Dantzer,et al.  In vitro and in vivo evidence for a role of the P2X7 receptor in the release of IL-1 beta in the murine brain. , 2008, Brain, behavior, and immunity.

[168]  M. Barrot,et al.  The transcription factor DeltaFosB is recruited by inflammatory pain. , 2006, Journal of neurochemistry.

[169]  D. Theobald,et al.  An essential role for DeltaFosB in the nucleus accumbens in morphine action. , 2006, Nature neuroscience.

[170]  E. Nestler,et al.  Delta FosB regulates wheel running. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[171]  M. Barrot,et al.  DeltaFosB: a sustained molecular switch for addiction. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[172]  R. North,et al.  Pharmacology of cloned P2X receptors. , 2000, Annual review of pharmacology and toxicology.